Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Sacchi

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Nano Letters|December 8, 2025
Silica Meta-Optics: When High Performance Does Not Need a High IndexLuca Sacchi, Alfonso Palmieri, Vitthal Mishra, et al.
Multiple Sclerosis and Related Disorders|July 10, 2021
Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysisTiziana Carandini, Luca Sacchi, Francesca Bovis, et al.
Alzheimer'S Research & Therapy|April 6, 2024
Utility of visual rating scales in primary progressive aphasiaNeus Falgàs, Luca Sacchi, Tiziana Carandini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2020
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppressionTiziana Carandini, Anna Margherita Pietroboni, Luca Sacchi, et al.
Journal of Alzheimer'S Disease : JAD|July 2, 2023
Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal DementiaFederica Sorrentino, Chiara Fenoglio, Luca Sacchi, et al.
Biomedicines|October 27, 2022
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's DiseaseMarina Arcaro, Chiara Fenoglio, Maria Serpente, et al.
Alzheimer'S Research & Therapy|September 17, 2022
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulationAndrea Arighi, Marina Arcaro, Giorgio Giulio Fumagalli, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2020
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic SyndromeTiziana Carandini, Luca Sacchi, Laura Ghezzi, et al.
Alzheimer'S Research & Therapy|October 17, 2019
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromesTiziana Carandini, Andrea Arighi, Luca Sacchi, et al.
Alzheimer'S Research & Therapy|February 13, 2022
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damageAnna M Pietroboni, Annalisa Colombi, Tiziana Carandini, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Nano Letters|December 8, 2025
Silica Meta-Optics: When High Performance Does Not Need a High IndexLuca Sacchi, Alfonso Palmieri, Vitthal Mishra, et al.
Multiple Sclerosis and Related Disorders|July 10, 2021
Distinct patterns of MRI lesions in MOG antibody disease and AQP4 NMOSD: a systematic review and meta-analysisTiziana Carandini, Luca Sacchi, Francesca Bovis, et al.
Alzheimer'S Research & Therapy|April 6, 2024
Utility of visual rating scales in primary progressive aphasiaNeus Falgàs, Luca Sacchi, Tiziana Carandini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 29, 2020
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppressionTiziana Carandini, Anna Margherita Pietroboni, Luca Sacchi, et al.
Journal of Alzheimer'S Disease : JAD|July 2, 2023
Klotho Gene Expression Is Decreased in Peripheral Blood Mononuclear Cells in Patients with Alzheimer's Disease and Frontotemporal DementiaFederica Sorrentino, Chiara Fenoglio, Luca Sacchi, et al.
Biomedicines|October 27, 2022
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer's DiseaseMarina Arcaro, Chiara Fenoglio, Maria Serpente, et al.
Alzheimer'S Research & Therapy|September 17, 2022
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulationAndrea Arighi, Marina Arcaro, Giorgio Giulio Fumagalli, et al.
Journal of Alzheimer'S Disease : JAD|December 16, 2020
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic SyndromeTiziana Carandini, Luca Sacchi, Laura Ghezzi, et al.
Alzheimer'S Research & Therapy|October 17, 2019
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromesTiziana Carandini, Andrea Arighi, Luca Sacchi, et al.
Alzheimer'S Research & Therapy|February 13, 2022
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damageAnna M Pietroboni, Annalisa Colombi, Tiziana Carandini, et al.
Pageof 3